Legal & General Group’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $575K | Buy |
80,045
+10,878
| +16% | +$78.1K | ﹤0.01% | 2404 |
|
|
2025
Q1 | $414K | Sell |
69,167
-374
| -0.5% | -$2.24K | ﹤0.01% | 2453 |
|
|
2024
Q4 | $542K | Buy |
69,541
+1,911
| +3% | +$14.9K | ﹤0.01% | 2432 |
|
|
2024
Q3 | $730K | Buy |
67,630
+330
| +0.5% | +$3.56K | ﹤0.01% | 2343 |
|
|
2024
Q2 | $567K | Buy |
67,300
+13,182
| +24% | +$111K | ﹤0.01% | 2381 |
|
|
2024
Q1 | $364K | Sell |
54,118
-700
| -1% | -$4.7K | ﹤0.01% | 2546 |
|
|
2023
Q4 | $322K | Buy |
54,818
+449
| +0.8% | +$2.64K | ﹤0.01% | 2606 |
|
|
2023
Q3 | $530K | Buy |
54,369
+439
| +0.8% | +$4.28K | ﹤0.01% | 2412 |
|
|
2023
Q2 | $639K | Buy |
53,930
+38,383
| +247% | +$454K | ﹤0.01% | 2376 |
|
|
2023
Q1 | $168K | Buy |
15,547
+1,128
| +8% | +$12.2K | ﹤0.01% | 2646 |
|
|
2022
Q4 | $167K | Buy |
14,419
+8,449
| +142% | +$97.7K | ﹤0.01% | 2682 |
|
|
2022
Q3 | $89K | Buy |
5,970
+2,203
| +58% | +$32.8K | ﹤0.01% | 2856 |
|
|
2022
Q2 | $34K | Buy |
3,767
+529
| +16% | +$4.78K | ﹤0.01% | 3081 |
|
|
2022
Q1 | $24K | Hold |
3,238
| – | – | ﹤0.01% | 3183 |
|
|
2021
Q4 | $28K | Hold |
3,238
| – | – | ﹤0.01% | 3170 |
|
|
2021
Q3 | $27K | Hold |
3,238
| – | – | ﹤0.01% | 3159 |
|
|
2021
Q2 | $26K | Buy |
+3,238
| New | +$26K | ﹤0.01% | 3189 |
|
|
2019
Q3 | – | Sell |
-741
| Closed | -$8K | – | 3363 |
|
|
2019
Q2 | $8K | Hold |
741
| – | – | ﹤0.01% | 3390 |
|
|
2019
Q1 | $13K | Hold |
741
| – | – | ﹤0.01% | 3202 |
|
|
2018
Q4 | $13K | Buy |
741
+554
| +296% | +$9.72K | ﹤0.01% | 3213 |
|
|
2018
Q3 | $8K | Hold |
187
| – | – | ﹤0.01% | 3340 |
|
|
2018
Q2 | $11K | Buy |
+187
| New | +$11K | ﹤0.01% | 3289 |
|